Stay updated on CY, Pembrolizumab, GVAX & SBRT in Locally Adv Pancreatic Ca Clinical Trial
Sign up to get notified when there's something new on the CY, Pembrolizumab, GVAX & SBRT in Locally Adv Pancreatic Ca Clinical Trial page.
Latest updates to the CY, Pembrolizumab, GVAX & SBRT in Locally Adv Pancreatic Ca Clinical Trial page
- Check5 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; this is a minor update with no impact on core content or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedAdded a Locations section with Maryland as a study site and removed the older Maryland Locations entry and HHS Vulnerability Disclosure link.SummaryDifference0.2%
- Check55 days agoChange DetectedRevision: v3.3.2 replaces v3.2.0; no study content or critical UI changes were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check62 days agoChange DetectedAn administrative government funding/operating status notice was removed. The study details, eligibility criteria, and contact information remain available on the page.SummaryDifference0.4%
- Check77 days agoChange DetectedNo significant additions or deletions detected for this page.SummaryDifference0.5%
- Check106 days agoChange DetectedUpdated operating status notice and version to v3.2.0, replacing v3.1.0.SummaryDifference4%
Stay in the know with updates to CY, Pembrolizumab, GVAX & SBRT in Locally Adv Pancreatic Ca Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CY, Pembrolizumab, GVAX & SBRT in Locally Adv Pancreatic Ca Clinical Trial page.